APIs and Excipients

Locking Fraudulent Materials Out of the Supply Chain

April 02, 2019

Supplier vetting and monitoring-plus comprehensive testing-ensure quality of raw materials.

FDA Approves New Treatment for Depression

March 07, 2019

Janssen’s Spravato (esketamine) gains approval with restricted distribution guidelines.

Biogen to Acquire Gene-Therapy Company Nightstar in $800-Million Deal

March 05, 2019

The acquisition will establish a clinical pipeline for Biogen of gene-therapy candidates in ophthalmology.

Strategic Screening for Solubility Solutions

March 02, 2019

Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.

Rising to the Challenge of Biologic Drug Formulation

March 02, 2019

As biologics continue to push boundaries, the industry needs to take a holistic approach to formulation to ensure success.

Mustang Bio, Nationwide Children’s Hospital Sign License Agreement for Oncolytic Virus Therapy

February 21, 2019

Mustang intends to combine an oncolytic virus with an interleukin-13 Rα2-(IL13Rα2)-specific chimeric antigen receptor to potentially enhance efficacy in treating glioblastoma multiforme.

SK Biopharmaceuticals, Arvelle Partner on Anti-Epileptic Drug for Europe

February 19, 2019

In a deal worth $530 million, the companies will develop and commercialize an anti-epileptic drug candidate in Europe.

AbbVie, Teneobio Partner on Multiple Myeloma Treatment

February 15, 2019

The partners will collaborate on the development and commercialization of a B-cell maturation antigen-targeting immunotherapeutic for treating multiple myeloma.

Novartis, AbCellera in Antibody Discovery Pact

February 14, 2019

Pharmaceutical Technology's In the Lab eNewsletter

The multi-year agreement will give Novartis access to AbCellera’s expertise and state-of-the-art antibody discovery technology for up to ten clinically-relevant disease targets.

Lipid Excipient Targets Multiple Dose Forms

February 05, 2019

A solid lipid excipient from ABITEC is designed for multiple dosing forms.